IMVT

Immunovant, Inc. IMVT

NasdaqMid CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$4.25B total
FMR LLC
$623.66M-4.5%
Deep Track Capital, LP
$359.91M-19.0%
BlackRock, Inc.
$276.68M+9.2%
FARALLON CAPITAL MANAGEMENT LLC
$223.67M+275.5%
BAKER BROS. ADVISORS LP
$209.42M-0.4%
STATE STREET CORP
$177.89M+1.7%
MORGAN STANLEY
$174.73M+17.0%
TCG Crossover Management, LLC
$171.77M0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC
$150.67M+5.5%
VANGUARD CAPITAL MANAGEMENT LLC
$140.20M+0.5%
JENNISON ASSOCIATES LLC
$127.54M+3.6%
RTW INVESTMENTS, LP
$122.44M0.0%
Two Seas Capital LP
$121.31M-1.7%
ADAR1 Capital Management, LLC
$89.80M-13.0%
GEODE CAPITAL MANAGEMENT, LLC
$86.12M+6.8%
T. Rowe Price Investment Management, Inc.
$85.62M-38.5%
Woodline Partners LP
$76.13M0.0%
PRICE T ROWE ASSOCIATES INC /MD/
$70.48M+438.6%
GOLDMAN SACHS GROUP INC
$67.47M-1.9%
ARMISTICE CAPITAL, LLC
$66.89M-51.3%
Alpine Global Management, LLC
$52.98M-47.9%
PERCEPTIVE ADVISORS LLC
$52.30M-15.0%
D. E. Shaw & Co., Inc.
$47.80MNew
BANK OF AMERICA CORP /DE/
$45.52M+32.2%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$39.40M+65.5%
See all 228 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q1 2027
EDGAR

EPS (Diluted)

Q1 2027
EDGAR

ROIC

Q1 2027
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/IMVT

Earnings Per Share

13fpro.ai/company/IMVT

Loading ratio trend…

IMVT insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Immunovant, Inc. (IMVT): stock profile, AI score and financials

Immunovant, Inc. (IMVT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. IMVT is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of IMVT by reported 13-F value include FMR, Deep Track Capital, BlackRock, based on the most recent SEC filings. IMVT trades on the Nasdaq exchange and files with the SEC under CIK 1764013. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IMVT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Immunovant, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1764013 →